Product Overview
XL413 | T3352 | TargetMol Chemicals
CAS: 1169558-38-6
Smiles: Clc1ccc2oc3c(nc([nH]c3=O)[C@@H]3CCCN3)c2c1
Formula: C14H12ClN3O2
Pathway: Cell Cycle/Checkpoint|||Chromatin/Epigenetic|||GPCR/G Protein|||JAK/STAT signaling|||Metabolism|||Stem Cells
Target: cholecystokinin|||Casein Kinase|||Pim|||CDK
Receptor: N/A
Bioactivity: XL-413 is an orally bioavailable cell division cycle 7 homolog (CDC7) kinase inhibitor with potential antineoplastic activity. XL-413 binds to and inhibits the activity of CDC7, which may result in the inhibition of DNA replication and mitosis, the induction of tumor cell apoptosis, and the inhibition of tumor cell proliferation in CDC7-overexpressing tumor cells.
Molecular Weight: 289, 72
